Oragest
Oragest Brand names, Oragest Analogs
- Amen
- Aragest
- Aragest 5
- Asconale
- Clinofem
- Clinovir
- Colirest
- Crinone
- Curretab
- Cycrin
- DMPA
- Depo-Clinovir
- Depo-Prodasone
- Depo-Progestin
- Depo-Promone
- Depo-Provera
- Depo-Subq Provera 104
- Depomedroxyprogesterone acetate
- Depot-Medroxyprogesterone acetate
- Farlutal
- Farlutin
- G-Farlutal
- Gestapuran
- Hematrol
- Hydroxymethylprogesterone
- Hysron
- Indivina
- Lunelle
- Lutopolar
- Lutoral
- MAP
- MPA
- Med-Pro
- Medroprogesterone Acetate
- Medrossiprogesterone [Dcit]
- Medroxiprogesterona [Inn-Spanish]
- Medroxiprogesteronum
- Medroxyprogesteron
- Medroxyprogesteron acetate
- Medroxyprogesterone acetate
- Medroxyprogesterone Base
- Medroxyprogesteronum [Inn-Latin]
- Meprate
- Metigestrona
- MPA Gyn 5
- Nadigest
- Nidaxin
- Novo-Medrone
- Oragest
- Perlutex
- Perlutex Leo
- Prempro/Premphase
- Prodasone
- Progestalfa
- Progestasert
- Progesterone
- Progeston
- Progevera
- Prometrium
- Provera
- Proverone
- Ralovera
- Repromap
- Repromix
- Sirprogen
- Sodelut G
- Veramix
Oragest Brand Names Mixture
- Lunelle (Medroxyprogesterone + Estradiol)
Oragest Chemical_Formula
C22H32O3
Oragest RX_link
http://www.rxlist.com/cgi/generic/medrox.htm
Oragest fda sheet
Oragest msds (material safety sheet)
Oragest Synthesis Reference
P. Ruggieri, C. Ferrari, U.S. Pat. 3,043,832 (1962)
Oragest Molecular Weight
344.488 g/mol
Oragest Melting Point
220 - 223.5 oC
Oragest H2O Solubility
22.2mg/L
Oragest State
Solid
Oragest LogP
3.606
Oragest Dosage Forms
Tablets; Depo injection
Oragest Indication
Used as a contraceptive and to treat amenorrhea, abnormal uterine bleeding, endometriosis, endometrial and renal cell carcinomas, and pulmonary disorders such as chronic obstructive pulmonary disease (COPD), Pickwickian syndrome, and other hypercapnic pulmonary conditions.
Oragest Pharmacology
Medroxyprogesterone is a synthetic progestin more potent than progesterone.
Oragest Absorption
Rapidly absorbed from GI tract
Oragest side effects and Toxicity
Side effects include loss of bone mineral density, BMD changes in adult women, bleeding irregularities, cancer risks, and thromboembolic disorders.
Oragest Patient Information
Oragest Organisms Affected
Humans and other mammals
